Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am J Transplant. 2020 Sep 15;21(1):314–321. doi: 10.1111/ajt.16277

TABLE 2.

Waitlisting rates and program-specific waitlisting rates ratios for programs in GA, NC, and SC, study years 2012–2015 (with follow-up through 2016)

At-risk patients
Numerator
Denominator
Waitlisting rate
Waitlisting rate ratioa
Transplant program Number referred 01/2012–12/2015 Number waitlisted 01/2012–12/2016 Referred patient-years Per 100 patient-years Observed/expected waitlisted (95% credible interval)
1 3517 906 7897.31 11.47 0.76 (0.71, 0.81)
2 1663 355 3728.92 9.52 0.77 (0.69, 0.85)
3 2003 547 4093.22 13.36 0.77 (0.71, 0.84)
4 1863 515 3996.99 12.88 0.79 (0.72, 0.86)
5 3713 1237 7187.37 17.21 1.01 (0.95, 1.07)
6 3087 935 5917.00 15.80 1.13 (1.06,1.21)
7 5592 2055 10726.66 19.16 1.20 (1.15,1.25)
8 1534 501 2482.32 20.18 1.29 (1.18,1.41)
9 1353 487 2252.80 21.62 1.33 (1.22, 1.46)
a

Expected waitlisted adjusted for patient age, sex, race, insurance status, and comorbidities at ESRD start.